Please login to read the full article.
Scrip Regulatory Affairs
UK industry code guides pharma on social media best practice
11 April 2011
Vibha Sharma
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US FDA explains how drug, device companies should deal with off-label use comments on social media sites
- France votes for more regulatory transparency, tighter safety monitoring and tougher promotion controls
- PDUFA V: predictability a key theme but US FDA urged to focus on safety too
- New guidance on regenerative medicinal products launched
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
